The establishment of EVISA is funded by the EU through
the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
Poisoning due to excessive intake of Se. Symptoms include hair and nail loss, skin lesions, damage to the nervous, immune and reproductive systems, convulsions, paralysis, gastrointestinal and circulatory disturbances.